Home » Media Center » News » Gornitzky represents Deutsche Bank in VBL Therapeutics’ USD 40 million IPO on NASDAQ.

October 06, 2014

Gornitzky represents Deutsche Bank in VBL Therapeutics’ USD 40 million IPO on NASDAQ.

Gornitzky represented the underwriters, led by Deutsche Bank, in the USD 40 million initial public offering of Vascular Biogenics Ltd. (operating as VBL Therapeutics) on the NASDAQ Global Market.

Deutsche Bank acted as book-running manager for the offering. JMP Securities and Oppenheimer & Co. acted as co-managers for the offering.

The underwriters were represented by Chaim Friedland (Partner), Ari Fried (Partner) and Yoav Meer.

Gornitzky represents Deutsche Bank in VBL Therapeutics’ USD 40 million IPO on NASDAQ.

KEY CONTACTS

Chaim Friedland

Ari Fried

RELATED PRACTICES

RELATED NEWS & PUBLICATIONS

Our Impact

Aviram Handel – Lecture at the Conference of the Court Administration for Legal Assistants at the Tel Aviv District Court

MICA Conference

Bittax

Institute of Business Arbitration Conference

Our firm represented Melisron Ltd. in a raise public debt of approximately 750 million NIS

The Jerusalem District Court approved foreign arbitration awards totaling approximately 100,000,000 NIS in favor of Hilton Worldwide against the French businessman Michel Ohayon

Gornitzky represented the underwriters in Similarweb’s USD 31.6 million secondary public offering on NYSE.

A lawsuit was filed for hundreds of thousands of shekels against tenants who refused to pay rent and management fees

Filing an appeal Against the Disqualification of Judge Amit from issuing a Ruling in the High Court of Justice

Accompaniment of OPC in the submission of a tender offer Sorek 3

Medical Center Transaction